Wyeth Sales Force Reorganization Will Not Wait For Competitive Response
Wyeth says it does not have an internal goal for the number of positions to be cut in its primary care sales force. The company raises its 2005 earnings guidance based on favorable sales trends.
More from Archive
More from Pink Sheet
• By
Recent and upcoming US FDA advisory committee meetings and a summary of the topics covered.
• By
The UK’s research-based pharma industry and medical research charities have set out clear action points to drive greater diversity and inclusion in clinical trials.
• By
Blenrep, GSK’s multiple myeloma therapy, faced a major setback when it was withdrawn from the market in 2022. The drug has since made a return as a second-line therapy, and is on track to being reimbursed in England.